Pantoea calida bacteremia in an adult with end-stage stomach cancer under inpatient care
Abstract Pantoea calida is a gram-negative bacillus that was first identified in 2010. Here, we describe the first known case of P. calida bacteremia in a 77-year-old woman with end-stage stomach cancer under inpatient care. The patient was admitted to our hospital for pain after receiving anti-canc...
Gespeichert in:
Veröffentlicht in: | Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2017-06, Vol.23 (6), p.407-409 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 409 |
---|---|
container_issue | 6 |
container_start_page | 407 |
container_title | Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy |
container_volume | 23 |
creator | Yamada, Kageto Kashiwa, Machiko Arai, Katsumi Satoyoshi, Kazuya Nishiyama, Hiroyuki |
description | Abstract Pantoea calida is a gram-negative bacillus that was first identified in 2010. Here, we describe the first known case of P. calida bacteremia in a 77-year-old woman with end-stage stomach cancer under inpatient care. The patient was admitted to our hospital for pain after receiving anti-cancer therapy at outpatient facility. Thirteen days after admission, her temperature rose to 39.6 °C. A blood culture was ordered for suspected bacterial infection, and the patient was treated empirically with ampicillin/sulbactam. Cultures showed white pitting colonies later identified as a Pantoea sp. by biochemical analysis. The isolate’s 16S rRNA sequence was identical to that of P. calida (100%), and showed 99.1% similarity with that of Pantoea gaviniae . Matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS) confirmed the species as P. calida with an average spectral score > 2.0. The primary isolate was ampicillin-resistant, but susceptible to other antibiotics and the bacteremia was cleared after three days of antibiotic therapy. Since P. calida infection is relatively rare, limited information exists on the pathogen’s portal of entry and bacterial characteristics; thus, further studies are necessary to establish the pathophysiological mechanisms P. calida infection. |
doi_str_mv | 10.1016/j.jiac.2017.01.001 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1865519350</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1341321X17300144</els_id><sourcerecordid>1865519350</sourcerecordid><originalsourceid>FETCH-LOGICAL-c435t-83140ac58afbdac38538531ddcaa592c9656c57c3d7085905c4fcac7290abcff3</originalsourceid><addsrcrecordid>eNp9kV-L1TAQxYso7rr6BXyQPvrSmmmaNgURZPEfLCiosG9h7mTqprbpNUmV_fam3NUHH4QhCeGcA_M7RfEURA0CuhdTPTmkuhHQ1wJqIeBecQ6t7Ku-1-J-fssWKtnA9VnxKMYpC3ql9cPirNHQQTO058X1J_RpZSwJZ2exPCAlDrw4LJ0vMY_d5lT-cummZG-rmPAblzGtC9JNNnniUG7e5tP5IybHPuXvwI-LByPOkZ_c3RfF17dvvly-r64-vvtw-fqqolaqVGkJrUBSGseDRZJa7QPWEqIaGho61ZHqSdpeaDUIRe1ISH0zCDzQOMqL4vkp9xjWHxvHZBYXiecZPa9bNKA7pWCQSmRpc5JSWGMMPJpjcAuGWwPC7ETNZHaiZidqBJgMLJue3eVvh4XtX8sfhFnw8iTgvOVPx8FEyhSIrQtMydjV_T__1T92mp13uY7vfMtxWrfgMz8DJjZGmM97p3ul0Mtsb1v5G5fMnGY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1865519350</pqid></control><display><type>article</type><title>Pantoea calida bacteremia in an adult with end-stage stomach cancer under inpatient care</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Yamada, Kageto ; Kashiwa, Machiko ; Arai, Katsumi ; Satoyoshi, Kazuya ; Nishiyama, Hiroyuki</creator><creatorcontrib>Yamada, Kageto ; Kashiwa, Machiko ; Arai, Katsumi ; Satoyoshi, Kazuya ; Nishiyama, Hiroyuki</creatorcontrib><description>Abstract Pantoea calida is a gram-negative bacillus that was first identified in 2010. Here, we describe the first known case of P. calida bacteremia in a 77-year-old woman with end-stage stomach cancer under inpatient care. The patient was admitted to our hospital for pain after receiving anti-cancer therapy at outpatient facility. Thirteen days after admission, her temperature rose to 39.6 °C. A blood culture was ordered for suspected bacterial infection, and the patient was treated empirically with ampicillin/sulbactam. Cultures showed white pitting colonies later identified as a Pantoea sp. by biochemical analysis. The isolate’s 16S rRNA sequence was identical to that of P. calida (100%), and showed 99.1% similarity with that of Pantoea gaviniae . Matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS) confirmed the species as P. calida with an average spectral score > 2.0. The primary isolate was ampicillin-resistant, but susceptible to other antibiotics and the bacteremia was cleared after three days of antibiotic therapy. Since P. calida infection is relatively rare, limited information exists on the pathogen’s portal of entry and bacterial characteristics; thus, further studies are necessary to establish the pathophysiological mechanisms P. calida infection.</description><identifier>ISSN: 1341-321X</identifier><identifier>EISSN: 1437-7780</identifier><identifier>DOI: 10.1016/j.jiac.2017.01.001</identifier><identifier>PMID: 28161294</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Aged ; Ampicillin - pharmacology ; Ampicillin - therapeutic use ; Anti-Bacterial Agents - pharmacology ; Anti-Bacterial Agents - therapeutic use ; Bacteremia ; Bacteremia - complications ; Bacteremia - diagnosis ; Bacteremia - microbiology ; Cancer ; Enterobacteriaceae Infections - complications ; Enterobacteriaceae Infections - diagnosis ; Enterobacteriaceae Infections - microbiology ; Female ; Hematology, Oncology and Palliative Medicine ; Hospitalization ; Humans ; Microbial Sensitivity Tests ; Pantoea - chemistry ; Pantoea - drug effects ; Pantoea - isolation & purification ; Pantoea calida ; Stomach Neoplasms - complications ; Sulbactam - pharmacology ; Sulbactam - therapeutic use</subject><ispartof>Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2017-06, Vol.23 (6), p.407-409</ispartof><rights>Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases</rights><rights>2017 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases</rights><rights>Copyright © 2017 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c435t-83140ac58afbdac38538531ddcaa592c9656c57c3d7085905c4fcac7290abcff3</citedby><cites>FETCH-LOGICAL-c435t-83140ac58afbdac38538531ddcaa592c9656c57c3d7085905c4fcac7290abcff3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28161294$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yamada, Kageto</creatorcontrib><creatorcontrib>Kashiwa, Machiko</creatorcontrib><creatorcontrib>Arai, Katsumi</creatorcontrib><creatorcontrib>Satoyoshi, Kazuya</creatorcontrib><creatorcontrib>Nishiyama, Hiroyuki</creatorcontrib><title>Pantoea calida bacteremia in an adult with end-stage stomach cancer under inpatient care</title><title>Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy</title><addtitle>J Infect Chemother</addtitle><description>Abstract Pantoea calida is a gram-negative bacillus that was first identified in 2010. Here, we describe the first known case of P. calida bacteremia in a 77-year-old woman with end-stage stomach cancer under inpatient care. The patient was admitted to our hospital for pain after receiving anti-cancer therapy at outpatient facility. Thirteen days after admission, her temperature rose to 39.6 °C. A blood culture was ordered for suspected bacterial infection, and the patient was treated empirically with ampicillin/sulbactam. Cultures showed white pitting colonies later identified as a Pantoea sp. by biochemical analysis. The isolate’s 16S rRNA sequence was identical to that of P. calida (100%), and showed 99.1% similarity with that of Pantoea gaviniae . Matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS) confirmed the species as P. calida with an average spectral score > 2.0. The primary isolate was ampicillin-resistant, but susceptible to other antibiotics and the bacteremia was cleared after three days of antibiotic therapy. Since P. calida infection is relatively rare, limited information exists on the pathogen’s portal of entry and bacterial characteristics; thus, further studies are necessary to establish the pathophysiological mechanisms P. calida infection.</description><subject>Aged</subject><subject>Ampicillin - pharmacology</subject><subject>Ampicillin - therapeutic use</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Bacteremia</subject><subject>Bacteremia - complications</subject><subject>Bacteremia - diagnosis</subject><subject>Bacteremia - microbiology</subject><subject>Cancer</subject><subject>Enterobacteriaceae Infections - complications</subject><subject>Enterobacteriaceae Infections - diagnosis</subject><subject>Enterobacteriaceae Infections - microbiology</subject><subject>Female</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Hospitalization</subject><subject>Humans</subject><subject>Microbial Sensitivity Tests</subject><subject>Pantoea - chemistry</subject><subject>Pantoea - drug effects</subject><subject>Pantoea - isolation & purification</subject><subject>Pantoea calida</subject><subject>Stomach Neoplasms - complications</subject><subject>Sulbactam - pharmacology</subject><subject>Sulbactam - therapeutic use</subject><issn>1341-321X</issn><issn>1437-7780</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kV-L1TAQxYso7rr6BXyQPvrSmmmaNgURZPEfLCiosG9h7mTqprbpNUmV_fam3NUHH4QhCeGcA_M7RfEURA0CuhdTPTmkuhHQ1wJqIeBecQ6t7Ku-1-J-fssWKtnA9VnxKMYpC3ql9cPirNHQQTO058X1J_RpZSwJZ2exPCAlDrw4LJ0vMY_d5lT-cummZG-rmPAblzGtC9JNNnniUG7e5tP5IybHPuXvwI-LByPOkZ_c3RfF17dvvly-r64-vvtw-fqqolaqVGkJrUBSGseDRZJa7QPWEqIaGho61ZHqSdpeaDUIRe1ISH0zCDzQOMqL4vkp9xjWHxvHZBYXiecZPa9bNKA7pWCQSmRpc5JSWGMMPJpjcAuGWwPC7ETNZHaiZidqBJgMLJue3eVvh4XtX8sfhFnw8iTgvOVPx8FEyhSIrQtMydjV_T__1T92mp13uY7vfMtxWrfgMz8DJjZGmM97p3ul0Mtsb1v5G5fMnGY</recordid><startdate>20170601</startdate><enddate>20170601</enddate><creator>Yamada, Kageto</creator><creator>Kashiwa, Machiko</creator><creator>Arai, Katsumi</creator><creator>Satoyoshi, Kazuya</creator><creator>Nishiyama, Hiroyuki</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20170601</creationdate><title>Pantoea calida bacteremia in an adult with end-stage stomach cancer under inpatient care</title><author>Yamada, Kageto ; Kashiwa, Machiko ; Arai, Katsumi ; Satoyoshi, Kazuya ; Nishiyama, Hiroyuki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c435t-83140ac58afbdac38538531ddcaa592c9656c57c3d7085905c4fcac7290abcff3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Aged</topic><topic>Ampicillin - pharmacology</topic><topic>Ampicillin - therapeutic use</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Bacteremia</topic><topic>Bacteremia - complications</topic><topic>Bacteremia - diagnosis</topic><topic>Bacteremia - microbiology</topic><topic>Cancer</topic><topic>Enterobacteriaceae Infections - complications</topic><topic>Enterobacteriaceae Infections - diagnosis</topic><topic>Enterobacteriaceae Infections - microbiology</topic><topic>Female</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Hospitalization</topic><topic>Humans</topic><topic>Microbial Sensitivity Tests</topic><topic>Pantoea - chemistry</topic><topic>Pantoea - drug effects</topic><topic>Pantoea - isolation & purification</topic><topic>Pantoea calida</topic><topic>Stomach Neoplasms - complications</topic><topic>Sulbactam - pharmacology</topic><topic>Sulbactam - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yamada, Kageto</creatorcontrib><creatorcontrib>Kashiwa, Machiko</creatorcontrib><creatorcontrib>Arai, Katsumi</creatorcontrib><creatorcontrib>Satoyoshi, Kazuya</creatorcontrib><creatorcontrib>Nishiyama, Hiroyuki</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yamada, Kageto</au><au>Kashiwa, Machiko</au><au>Arai, Katsumi</au><au>Satoyoshi, Kazuya</au><au>Nishiyama, Hiroyuki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pantoea calida bacteremia in an adult with end-stage stomach cancer under inpatient care</atitle><jtitle>Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy</jtitle><addtitle>J Infect Chemother</addtitle><date>2017-06-01</date><risdate>2017</risdate><volume>23</volume><issue>6</issue><spage>407</spage><epage>409</epage><pages>407-409</pages><issn>1341-321X</issn><eissn>1437-7780</eissn><abstract>Abstract Pantoea calida is a gram-negative bacillus that was first identified in 2010. Here, we describe the first known case of P. calida bacteremia in a 77-year-old woman with end-stage stomach cancer under inpatient care. The patient was admitted to our hospital for pain after receiving anti-cancer therapy at outpatient facility. Thirteen days after admission, her temperature rose to 39.6 °C. A blood culture was ordered for suspected bacterial infection, and the patient was treated empirically with ampicillin/sulbactam. Cultures showed white pitting colonies later identified as a Pantoea sp. by biochemical analysis. The isolate’s 16S rRNA sequence was identical to that of P. calida (100%), and showed 99.1% similarity with that of Pantoea gaviniae . Matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS) confirmed the species as P. calida with an average spectral score > 2.0. The primary isolate was ampicillin-resistant, but susceptible to other antibiotics and the bacteremia was cleared after three days of antibiotic therapy. Since P. calida infection is relatively rare, limited information exists on the pathogen’s portal of entry and bacterial characteristics; thus, further studies are necessary to establish the pathophysiological mechanisms P. calida infection.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>28161294</pmid><doi>10.1016/j.jiac.2017.01.001</doi><tpages>3</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1341-321X |
ispartof | Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2017-06, Vol.23 (6), p.407-409 |
issn | 1341-321X 1437-7780 |
language | eng |
recordid | cdi_proquest_miscellaneous_1865519350 |
source | MEDLINE; Alma/SFX Local Collection |
subjects | Aged Ampicillin - pharmacology Ampicillin - therapeutic use Anti-Bacterial Agents - pharmacology Anti-Bacterial Agents - therapeutic use Bacteremia Bacteremia - complications Bacteremia - diagnosis Bacteremia - microbiology Cancer Enterobacteriaceae Infections - complications Enterobacteriaceae Infections - diagnosis Enterobacteriaceae Infections - microbiology Female Hematology, Oncology and Palliative Medicine Hospitalization Humans Microbial Sensitivity Tests Pantoea - chemistry Pantoea - drug effects Pantoea - isolation & purification Pantoea calida Stomach Neoplasms - complications Sulbactam - pharmacology Sulbactam - therapeutic use |
title | Pantoea calida bacteremia in an adult with end-stage stomach cancer under inpatient care |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T16%3A20%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pantoea%20calida%20bacteremia%20in%20an%20adult%20with%20end-stage%20stomach%20cancer%20under%20inpatient%20care&rft.jtitle=Journal%20of%20infection%20and%20chemotherapy%20:%20official%20journal%20of%20the%20Japan%20Society%20of%20Chemotherapy&rft.au=Yamada,%20Kageto&rft.date=2017-06-01&rft.volume=23&rft.issue=6&rft.spage=407&rft.epage=409&rft.pages=407-409&rft.issn=1341-321X&rft.eissn=1437-7780&rft_id=info:doi/10.1016/j.jiac.2017.01.001&rft_dat=%3Cproquest_cross%3E1865519350%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1865519350&rft_id=info:pmid/28161294&rft_els_id=1_s2_0_S1341321X17300144&rfr_iscdi=true |